Skip to main content
. 2023 Jan 1;17(1):48–55. doi: 10.18502/ijhoscr.v17i1.11713

Table 2.

Adjuvant chemotherapy

Regimen N=72(%)
FEC→T 5-Fluorouracil-Epirubicin-Cyclophosphamide,
Docetaxel
22 (30.56)
AC→Pacli Doxorubicin-Cyclophosphamide, Paclitaxel 12 (16.67)
T Carbo Docetaxel-Carboplatin 6 (8.33)
AT Doxorubicin-Docetaxel 5 (6.94)
TAC Doxorubicin-Cyclophosphamide-Docetaxel 5 (6.94)
AET Doxorubicin-Epirubicin-Docetaxel 3 (4.17)
E-Pacli Epirubicin-Paclitaxel 3 (4.17)
ET-Carbo Epirubicin-Docetaxel-Carboplatin 3 (4.17)
Others FAC, EC-Pacli, A-Pacli, TC, TE, FEC, CMF, AT-Carbo 13 (18.06)